Rethinking Biomarkers for Combination Chemoimmunotherapy

J Thorac Oncol. 2023 Jul;18(7):841-843. doi: 10.1016/j.jtho.2023.04.015.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Biomarkers
  • Humans
  • Immunotherapy
  • Lung Neoplasms* / drug therapy

Substances

  • Biomarkers